Explore evidence

0.96 p-valueNo significant differences in infant mortality were found between treatment arms (p = 0.96).

Burkina Fasomortalité infantilepublished 2019Malaria journaleurope_pmcdocument of 6 observations

3.5 %Among 198 blood donors in Ouagadougou, Burkina Faso, EBV/CMV/HHV-6 co-infection was found in 3.5% (7/198).

Burkina FasoCytomegalovirus · Herpes virus 6 · virus Epstein-Barrpublished 2016The Pan African medical journaleurope_pmcdocument of 8 observations

87.7 %In Sector 6, the simple malaria morbidity rate among people over 5 years of age was 87.70% in 2023.

Burkina Fasopaludismeobserved 2023HAL · Unilimdocument of 110 observations

There was no correlation between HBV read numbers and qPCR viral loads, where high viral loads were observed regardless of read numbers.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

86.9 %At day 28, the PCR-corrected adequate clinical and parasitological response (ACPR) was 86.9% in the intention-to-treat population receiving the dispersible-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublished 2018Antimicrobial agents and chemotherapyeurope_pmcdocument of 10 observations

67 %Douze des 18 résultats positifs pour le virus de l'hépatite B détectés par mNGS ont été confirmés par PCR conventionnelle, soit 67 %.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

3.7 %In Orodara, the sporozoite infection rate (SIR) was 3.7% in year 3.

Burkina Fasopaludismeobserved year 3HAL · Unilimdocument of 87 observations

3.9 %Plasmodium ovale was identified in 3.9% of all infections.

Burkina Fasopaludismepublished 2008Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/1475-2875-7-174

80 %Among 742 enrolled COVID-19 patients with valid malaria tests in western Kenya and Burkina Faso, 591 (80%) did not have malaria co-infection.

Burkina FasoCOVID-19observed between Jan 8, 2021 and Jan 24, 2022published 2026The Lancet. Global healthPubMeddocument of 8 observations

41.5 %Among HIV-negative women, Candida albicans colonization was identified in 41.5%.

Burkina FasoCandida albicans colonizationpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950

27 %The prevalence of fever due to malaria after travelling to a tropical country ranges from 27% to 52%.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

2.9 %The prevalence rate of treponematosis among 6375 volunteer blood donors in Ouagadougou, Burkina Faso, was 2.9% according to Rapid Plasma Reagin (RPR) testing.

Burkina Fasotreponematosispublished 2014The Pan African medical journaleurope_pmcdocument of 7 observations

24.3 %Common bacterial pathogens of nasopharynx accounted for 24.3% of non-malaria infections in febrile children under 5 years of age in rural Burkina Faso.

Burkina Fasocommon bacterial pathogens of nasopharynxpublished 2018Infectious diseases of povertyeurope_pmcdocument of 11 observations

0 samplesNone of the 101 genotyped samples had the Pfdhfr I164L mutation.

Burkina Fasopaludismeobserved 2010published 2017Malaria journaleurope_pmcdocument of 10 observations

54.2 %In 376 of 694 (54.2%) included children, malaria was microscopically confirmed.

Burkina Fasopaludismepublished 2014Malaria journaleurope_pmcdocument of 3 observations

20 %Among 742 enrolled COVID-19 patients with valid malaria tests in western Kenya and Burkina Faso, 151 (20%) had Plasmodium falciparum malaria co-infection.

Burkina FasoCOVID-19 · paludismeobserved between Jan 8, 2021 and Jan 24, 2022published 2026The Lancet. Global healthPubMeddocument of 8 observations

An. gambiae s.l. was resistant to DDT and cross-resistant to pyrethroids at the two sites.

Burkina Fasopaludismeobserved 2008published 2012Parasites & vectorseurope_pmcdocument of 5 observationsDOI 10.1186/1756-3305-5-127

0.751 Pearson_rThere is a positive correlation between anti-major repeat IgG and full-length anti-PfCSP4/38 IgG at D180 (r = 0.7514, P = 0.0001).

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

15 %In the dry season, 213 out of 1,382 patients without fever (15%) had a Plasmodium falciparum infection in Burkina Faso.

Burkina Fasopaludismeobserved dry seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192

3.9 %HCV prevalence was 3.9% among the 462 screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite Cobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

1.8 %Au Burkina Faso, l'examen microscopique a détecté une prévalence de 1,8 % d'infections à P. ovale chez 830 enfants âgés de trois à quinze ans.

Burkina FasopaludismeHAL · Unilimdocument of 80 observations

83 %The proportion of infant deaths that occurred in the neonatal period ranged from 8 to 83%, with a median of 53%.

Burkina Fasoinfant deaths · neonatal periodobserved 2009 to 2014published 2019International journal of public healtheurope_pmcdocument of 7 observations

4,116 childrenAmong the 4,116 children (6-59 months old) enrolled and followed up for 28 days post treatment, a total of 6,238 adverse events were reported.

Burkina Fasopaludismepublished 2014PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0096388

1,647 episodesGastrointestinal infections occurred in 1647 episodes in the azithromycin group and 1985 episodes in the placebo group.

Burkina Faso · Maligastrointestinal infectionspublished 2019The New England journal of medicineeurope_pmcdocument of 4 observations

4 %HepB IgG pool showed 4% inhibition of parasite liver burden compared to naïve controls in the transgenic sporozoite challenge model.

Burkina FasopaludismeHAL · Unilimdocument of 39 observations